Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thinking about stopping treatment for panic disorder.

R L DuPont1

  • 1Institute for Behavior and Health Inc., Rockville, MD 20852.

The Journal of Clinical Psychiatry
|December 1, 1990
PubMed
Summary

Long-term use of benzodiazepines for panic disorder requires careful consideration due to potential dependence. Differentiating chemical from physical dependence guides safe discontinuation strategies for these antipanic medications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biology and the environment-rethinking demand reduction.

Journal of addictive diseases·2000
Same author

Impairment in pure and comorbid generalized anxiety disorder and major depression at 12 months in two national surveys.

The American journal of psychiatry·1999
Same author

Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder.

The Journal of clinical psychiatry·1999
Same author

Twelve-step and mutual-help programs for addictive disorders.

The Psychiatric clinics of North America·1999
Same author

The origins of the Minnesota model of addiction treatment--a first person account.

Journal of addictive diseases·1999
Same author

Examining the debate on the use of medical marijuana.

Proceedings of the Association of American Physicians·1999

Area of Science:

  • Psychiatry and Pharmacology
  • Neuroscience of Addiction and Dependence

Background:

  • Panic disorder is a chronic condition often requiring long-term treatment with antipanic medications.
  • Benzodiazepines are commonly prescribed for panic disorder but raise concerns regarding their long-term safety and addictive potential.
  • Understanding the nuances between chemical and physical dependence is crucial for managing benzodiazepine use and discontinuation.

Purpose of the Study:

  • To clarify the distinction between chemical dependence and physical dependence in the context of benzodiazepine use for panic disorder.
  • To highlight the specific risks of addiction in patients with a dual diagnosis of panic disorder and chemical dependence.
  • To propose a differentiated approach to benzodiazepine discontinuation based on the type of dependence.

Main Methods:

  • Review of existing literature on benzodiazepine pharmacology, dependence, and treatment of panic disorder.
  • Analysis of patient profiles with dual diagnoses (panic disorder and chemical dependence) versus those with physical dependence.
  • Development of a structured, four-step discontinuation protocol applicable to both patient groups.

Main Results:

  • Benzodiazepines are generally safe and effective antipanic medications.
  • Patients with panic disorder and chemical dependence face a higher risk of addiction compared to those developing physical dependence.
  • Physical dependence can occur without addiction, allowing for successful discontinuation once panic symptoms are managed.

Conclusions:

  • A tailored approach to benzodiazepine use and discontinuation is essential, differentiating between chemical and physical dependence.
  • The proposed four-step discontinuation strategy offers a framework for managing benzodiazepine withdrawal in patients with panic disorder.
  • Effective management strategies are crucial for long-term treatment of panic disorder while mitigating risks associated with benzodiazepine therapy.

Related Experiment Videos